COCRYSTAL PHARMA, INC.

Capabilities

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and clinical advancement of innovative antiviral therapeutics for serious and chronic viral diseases. The company employs a proprietary structure-based drug discovery platform supported by Nobel Prize–winning scientific expertise to design first- and best-in-class small-molecule antivirals that target highly conserved viral replication enzymes. This approach enables efficient identification, optimization, and development of broad-spectrum antiviral drug candidates. Cocrystal Pharma’s pipeline includes clinical and preclinical programs addressing influenza, norovirus, coronaviruses including SARS-CoV-2, hepatitis C, and other high-priority viral pathogens. The company has successfully advanced multiple programs through Phase 1 and Phase 2 clinical trials and collaborates with government agencies and global pharmaceutical partners to address critical public health needs.